More Research

Mereo BioPharma

Path cleared for partnering of acumapimod (BCT-197)
Lighthouse | 16 Apr 2019

Hutchison China MediTech

Proposed listing in Hong Kong and global offering
Lighthouse | 15 Apr 2019

Hutchison China MediTech

AACR 2019: Savolitinib in the spotlight in NSCLC
Update | 09 Apr 2019

BerGenBio

Efficacy endpoint met in Phase II AML study
Lighthouse | 02 Apr 2019

BerGenBio

Further support for bemcentinib’s broad potential from preclinical data at AACR
Lighthouse | 01 Apr 2019

Nexstim

Terms of the rights issue announced
Lighthouse | 28 Mar 2019

Hutchison China MediTech

Bringing Global Innovation and China Oncology into focus
Update | 21 Mar 2019

Nexstim

Securing the commercial future of NBT in depression
Update | 18 Mar 2019

Hutchison China MediTech

FY18 results as expected, plentiful news flow in FY19
Lighthouse | 11 Mar 2019

e-therapeutics

Setting the stage
Update | 06 Mar 2019

1 2 3 4 … 10
Return to Scancell
© 2019 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).